2026 medicine Nobel: optogenetics partially restored one man’s sight in a trial


The light-control technique was used with gene delivery and special goggles in a vision trial. The result in one man does not establish a generally effective treatment.
The technique recognised by the 2026 medicine Nobel has also been tested in a human vision trial. The Guardian reports that optogenetics partially restored sight in one man who had become blind from retinitis pigmentosa, a condition that damages light-sensitive cells in the retina, the layer at the back of the eye.
Karl Deisseroth, Peter Hegemann and Georg Nagel were awarded the 2026 Nobel Prize in Physiology or Medicine on October 5 for optogenetics—a technique that lets researchers control neurons, the brain’s nerve cells, with pulses of light. By changing activity in selected cells, researchers can test how those cells affect brain function, Nature reported.
Deisseroth is at Stanford University in California, Hegemann at Humboldt University of Berlin and Nagel at the University of Würzburg in Germany. The three share the 12 million Swedish kronor prize, worth about US$1.2 million, equally.
Working together in the early 2000s, Hegemann and Nagel discovered a light-sensitive protein called channelrhodopsin in the alga Chlamydomonas reinhardtii, which can swim towards light. Blue light makes the protein open, allowing charged molecules into a cell and creating a small electrical charge.
Deisseroth and his colleagues later inserted the gene encoding channelrhodopsin—the instructions for making the protein—into rodent neurons. They found that the cells could fire and communicate with other neurons. Using genetics to make particular types of brain cells controllable with light became known as optogenetics.

Deisseroth said optogenetic tools can turn individual cells, types of cell or connections between brain regions on or off with millisecond precision—a millisecond is one thousandth of a second. Researchers can make these changes while an animal is behaving or carrying out a mental task. This lets them test whether the selected neural activity contributes to brain function, rather than simply observing that the activity and behaviour occur together.
Alexander Gottschalk, a neuroscientist at Goethe University Frankfurt who has worked with all three winners, told Nature that optogenetics has had a major impact on basic science. He highlighted how precisely researchers can select which cells become responsive to light.
Nature reports that insights from optogenetic tools have helped researchers understand healthy brain function and conditions including depression, schizophrenia, Parkinson’s and Alzheimer’s.
Rui Costa, a neuroscientist and president and chief executive of the Allen Institute in Seattle, told Nature that the laureates’ work fundamentally changed neuroscience, influenced other areas of biology and opened new therapeutic possibilities. Costa’s assessment concerns possibilities for treatment, not established therapies for those conditions.
In the vision trial, a virus delivered genetic instructions for making the light-sensitive protein channelrhodopsin into retinal ganglion cells—nerve cells in the retina—in the man's eyes, the Guardian reports. He then used goggles that captured images of his surroundings, converted them into images using a single wavelength of light and projected them onto his retina in light pulses. The partial restoration of sight in this one person does not establish how well the approach would work for other patients or make it an established treatment.
The agency reports no evidence of ongoing transmission, but the unconfirmed diagnosis prevents it from judging whether Russia’s seven-day contact monitoring was sufficient.
8 min

A Tohoku University experiment found gains on later days in an eye-movement task. Rhythmic changes in brain blood volume were associated with better learning, but have not been shown to cause it.
2 min

Seeing a clinician, receiving medication and staying on it are different steps. A study of nearly 230,000 diagnosed young people found gaps across those stages.
4 min